Use and impact of high intensity treatments in patients with traumatic brain injury across Europe: a CENTER-TBI analysis
Open Access
- 23 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-13
- https://doi.org/10.1186/s13054-020-03370-y
Abstract
To study variation in, and clinical impact of high Therapy Intensity Level (TIL) treatments for elevated intracranial pressure (ICP) in patients with traumatic brain injury (TBI) across European Intensive Care Units (ICUs). We studied high TIL treatments (metabolic suppression, hypothermia (< 35 °C), intensive hyperventilation (PaCO2 < 4 kPa), and secondary decompressive craniectomy) in patients receiving ICP monitoring in the ICU stratum of the CENTER-TBI study. A random effect logistic regression model was used to determine between-centre variation in their use. A propensity score-matched model was used to study the impact on outcome (6-months Glasgow Outcome Score-extended (GOSE)), whilst adjusting for case-mix severity, signs of brain herniation on imaging, and ICP. 313 of 758 patients from 52 European centres (41%) received at least one high TIL treatment with significant variation between centres (median odds ratio = 2.26). Patients often transiently received high TIL therapies without escalation from lower tier treatments. 38% of patients with high TIL treatment had favourable outcomes (GOSE ≥ 5). The use of high TIL treatment was not significantly associated with worse outcome (285 matched pairs, OR 1.4, 95% CI [1.0–2.0]). However, a sensitivity analysis excluding high TIL treatments at day 1 or use of metabolic suppression at any day did reveal a statistically significant association with worse outcome. Substantial between-centre variation in use of high TIL treatments for TBI was found and treatment escalation to higher TIL treatments were often not preceded by more conventional lower TIL treatments. The significant association between high TIL treatments after day 1 and worse outcomes may reflect aggressive use or unmeasured confounders or inappropriate escalation strategies. Substantial variation was found in the use of highly intensive ICP-lowering treatments across European ICUs and a stepwise escalation strategy from lower to higher intensity level therapy is often lacking. Further research is necessary to study the impact of high therapy intensity treatments. The core study was registered with ClinicalTrials.gov, number NCT02210221, registered 08/06/2014, https://clinicaltrials.gov/ct2/show/NCT02210221?id=NCT02210221&draw=1&rank=1 and with Resource Identification Portal (RRID: SCR_015582).Keywords
Funding Information
- Seventh Framework Programme (602150)
This publication has 22 references indexed in Scilit:
- Hypothermia for Intracranial Hypertension after Traumatic Brain InjuryThe New England Journal of Medicine, 2015
- Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI)Neurosurgery, 2015
- Barbiturates for acute traumatic brain injuryEmergencias, 2012
- Decompressive Craniectomy in Diffuse Traumatic Brain InjuryThe New England Journal of Medicine, 2011
- Predicting Outcome after Traumatic Brain Injury: Development and International Validation of Prognostic Scores Based on Admission CharacteristicsPLoS Medicine, 2008
- AcknowledgmentsJournal of Neurotrauma, 2007
- Editor's CommentaryJournal of Neurotrauma, 2007
- Reliability and validity of the Pediatric Intensity Level of Therapy (PILOT) scale: A measure of the use of intracranial pressure–directed therapiesCritical Care Medicine, 2006
- Outcome following decompressive craniectomy for malignant swelling due to severe head injuryJournal of Neurosurgery, 2006
- Pressure-volume index in head injuryJournal of Neurosurgery, 1987